Furthermore, correlation of our diagnostic analyses with retrospective clinical data revealed an association between the concentration of specific complement markers C3a, C5a and tumor differentiation (Figure 6A–6C) and extension (Figure 6D–6F) in serum from OSCC patients compared to healthy controls. The gene discussed is C5; the disease is neoplasm.